Mydecine Innovations Group, Inc. is a biotechnology company, which engages in the research, drug development, and clinical trials of psilocybin products. The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A
Frequently Asked Questions
What is Mydecine Innovations Group Inc - Ordinary Shares New stock price today?
Mydecine Innovations Group Inc - Ordinary Shares New stock price today is $0.185.
What was Mydecine Innovations Group Inc - Ordinary Shares New stock price yesterday?
Mydecine Innovations Group Inc - Ordinary Shares New stock price yesterday was $0.135.